Keryx Biopharmaceuticals, Inc. News 
 
    NEW YORK, Nov. 26 -- Keryx Biopharmaceuticals, Inc. (Nasdaq: KERX; AIM: 
KRX), today announced that application has been made to the London Stock 
Exchange for admission to trading on the Alternative Investment Market of 
3,529,413 shares of common stock, par value $0.001 (the "new ordinary shares"). 
    These shares are being issued pursuant to the private equity investment 
into Keryx by institutional investors announced on 18 November 2003. The new 
ordinary shares will rank pari passu with the existing shares in issue and are 
expected to be admitted to the Alternative Investment Market at 8.00am on 26 
November 2003. 
 
    Contact: 
     Ron Bentsur, VP Finance and Investor Relations  
     Keryx Biopharmaceuticals, Inc. 
     212-531-5965 
     ron@keryx.com 
    
SOURCE  Keryx Biopharmaceuticals, Inc.  
    -0-                             11/26/2003 
    /CONTACT:  Ron Bentsur, VP Finance and Investor Relations of Keryx 
Biopharmaceuticals, Inc., +1-212-531-5965, ron@keryx.com/ 
    /Web site:  http://www.keryx.com / 
    (KERX) 
 






END